Indications

• Duodenal ulcer and benign gastric ulcer
  
  
• Post-operative ulcer.
  
  
• Oesophageal reflux disease.
  
  
• Zollinger-Ellison Syndrome.
  
  
• Prophylaxis of stress ulceration in seriously ill patients.
  
  
• Prophylaxis of recurrent haemorrhage from peptic ulcer.
  
  
• Prophylaxis of Mendelson's syndrome.
  
  
  

Key Benefits

• It is a specific rapidly acting histamine H2-antagonist
  
  
• It inhibits basal and stimulated secretion of gastric acid
  
  
• Ranitidine has a relatively long duration of action and it effectively suppresses gastric acid secretion for twelve hours